Can you provide the last earnings date for ERNEXA THERAPEUTICS INC?
ERNEXA THERAPEUTICS INC (ERNA) last reported earnings on 3/10/2026.
NASDAQ:ERNA • US1140823089
Past quarterly earnings results for ERNEXA THERAPEUTICS INC (ERNA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | - | - | - | -100.00% | ||||
| Q2 2025 | - | - | - | -100.00% | ||||
| Q1 2025 | - | - | - | -100.00% | ||||
| Q4 2024 | - | - | 1K | - | -94.12% | |||
| Q3 2024 | - | - | 487K | - | 874.00% | |||
| Q2 2024 | - | - | 47K | - | - | |||
| Q1 2024 | - | - | 47K | - | - | |||
| Q4 2023 | - | - | 17K | - | - | |||
| Q3 2023 | -1.03 | - | 97.24% | 50K | - | - | ||
| Q2 2023 | - | - | - | - | ||||
| Q1 2023 | - | - | - | - | ||||
| Q4 2022 | - | - | - | - | ||||
| Q3 2022 | -37.35 | -33.66 | -10.96% | -13.18% | - | - | ||
| Q2 2022 | -18.00 | -39.78 | 54.75% | - | - | - | ||
| Q1 2022 | -51.00 | -42.84 | -19.05% | - | - | - | ||
| Q4 2021 | -48.00 | -38.25 | -25.49% | - | - | -100.00% | ||
| Q3 2021 | -33.00 | -24.48 | -34.80% | - | - | -100.00% | ||
| Q2 2021 | - | - | - | -100.00% | ||||
| Q1 2021 | - | - | - | -100.00% | ||||
| Q4 2020 | - | - | 1.18M | - | - | |||
| Q3 2020 | - | - | 1.48M | - | - | |||
| Q2 2020 | - | - | 750K | - | - | |||
| Q1 2020 | - | - | 2.39M | - | - |
Notes
ERNEXA THERAPEUTICS INC (ERNA) last reported earnings on 3/10/2026.
ERNEXA THERAPEUTICS INC (ERNA) missed EPS estimates and missed revenue estimates in the most recent quarter.